Multicenter, Prospective, Non-randomized, Single-arm, Interventional Study for the Evaluation of the Safety and Preformance of the SRS Device for the Treatment of Pelvic Organ Prolapse

The SRS implant is intended for transvaginal surgical treatment of anterior vaginal wall prolapse with or without vaginal apex/uterine prolapses

Inclusion criteria

• Patient has signed the informed consent form and is willing to participate in the clinical study and data collection.
• Patient age is between 50 and 75 years old
• POP-Q: Aa and/or Ba is at least -1

Exclusion criteria

• Patient is pregnant or breastfeeding
• Patient is suffering from active infection (on antibiotic therapy)
• Patient is planning vaginal delivery
• Patient had previous vaginal mesh surgery
• Patient is in high risk for surgery (evidence of clinically significant cardiovascular, renal, hepatic, coagulatory or respiratory diseases).
• Any condition that in the judgment of the investigators would interfere with the subject's ability to provide informed consent, comply with study instructions, place the subject at increased risk, or which might confound interpretation of study results.
• Malignancy.
• Known hypersensitivity to PEEK and/or polypropylene materials.
• Participation in another investigational trial that has not completed the primary endpoint or interferes with study participation.
• Diagnosed with mental or emotional disturbance.